Platelets, glycoprotein Ib-IX, and von Willebrand factor are required for FeCl₃-induced occlusive thrombus formation in the inferior vena cava of mice

References

• Heit JCA. Office of the surgeon general. Proceedings of the surgeon general's workshop on deep vein thrombosis., In 2006, Washington, DC, USA: Department of Health and Human Services. Slide 11. Available at: http://www.surgeongeneral.gov/library/conference/deepvein/heit_epid_text.html
   Google Scholar
• Heit JA. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost 2005; 3: 1611–1617
   PubMed Web of Science ®Google Scholar
• Silverstein MD, Heit JA, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ, 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population based study. Arch Intern Med 1998; 158: 585–593
   PubMed Web of Science ®Google Scholar
• Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008; 451: 914–918
   PubMed Web of Science ®Google Scholar
• Rosen ED, Gailani D, Castellino FJ. FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse. Thromb Haemost 2002; 87: 774–776
   PubMed Web of Science ®Google Scholar
• Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol 2009; 6: 399–409
   PubMed Web of Science ®Google Scholar
• Fuster V, Stein B, Ambrose JA, Badimon L, Badimon JJ, Chesebro JH. Atherosclerotic clot rupture and thrombosis. Evolving concepts. Circulation 1990; 82: 1147–1159
   PubMed Web of Science ®Google Scholar
• van Zanten GH, de Graaf S, Slootweg PJ, Heijen HF, Connolly TM, de Groot PJ, Sixma JJ. Increased platelet deposition on atherosclerotic coronary arteries. J Clin Invest 1994; 93: 615–632
   PubMed Web of Science ®Google Scholar
• Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost 2006; 4: 2014–2021
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, George T, Cifuni SM, Ruggeri ZM, Ware J, Wagner DD. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006; 103: 16900–16905
   PubMed Web of Science ®Google Scholar
• Liu J, Fitzgerald ME, Berndt MC, Jackson CW, Gartner TK. Bruton tyrosine kinase is essential for botrocetin/vWF-induced signaling and GPIbα dependent thrombus formation in vivo. Blood 2006; 108: 2596–2603
   PubMed Web of Science ®Google Scholar
• Liu J, Joglekar M, Ware J, Fitzgerald ME, Lowell CA, Berndt MC, Gartner TK. Evaluation of the physiological significance of botrocetin/von Willebrand factor in vitro signaling. J Thromb Haemost 2008; 6: 1915–1922
   PubMed Web of Science ®Google Scholar
• Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385–392
   PubMed Web of Science ®Google Scholar
• Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, Fassler R, Hynes RO, Wagner DD. Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci USA 2003; 100: 2415–2419
   PubMed Web of Science ®Google Scholar
• Chauhan AK, Kisucka J, Lamb CB, Bergemeier W, Wagner DD. Von Willebrnad factor and factor VIII are independently required to form stable occlusive thrombi in injured veins. Blood 2007; 109: 2424–2429
   PubMed Web of Science ®Google Scholar
• Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289–297
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Dopheide SM, Yap CL, Ravanat C, Fruend M, Mangin P, Heel KA, Street A, Harper IS, Lanza F, et al. A revised model of platelet aggregation. J Clin Invest 2000; 105: 783–791
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Dent JA, Saldivar E. Contribution of distinct adhesive interactions of platelet aggregation in flowing blood. Blood 1999; 94: 172–178
   PubMed Web of Science ®Google Scholar
• Badimon L, Badimon JJB, Turrito VT, Fuster V. Role of von Willebrand factor in mediation platelet-vessel wall Interaction at low shear rate; the importance of perfusion conditions. Blood 1989; 73: 961–967
   PubMed Web of Science ®Google Scholar
• Kroll MH, Hellums JD, Mclntire LV, Schafer AI, Moake JL. Platelets and shear stress. Blood 1996; 88: 1525–1541
   PubMed Web of Science ®Google Scholar
• Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939–2950
   PubMed Web of Science ®Google Scholar
• Schneider SW, Nuschele S, Wixforth A, Gorzelanny C, Alexander-Katz A, Netz RR, Schneider MF. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers. Proc Natl Acad Sci USA 2007; 104: 7899–7903
   PubMed Web of Science ®Google Scholar
• Elvers M, Stegner D, Hagedorn I, Kleinschnitz C, Braun A, Kuijpers ME, Boesl M, Chen Q, Heemskerk JW, Stoll G, et al. Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal 2010; 3: ra1, 1–10
   Web of Science ®Google Scholar
• Brill A, Fuchs TA, Chauhan AK, Yang JJ, De Meyer SF, Köllnberger M, Wakefield TW, Lämmle B, Massberg S, Wagner DD. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011; 117: 1400–1407
   PubMed Web of Science ®Google Scholar
• Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: The Bernard-Soulier syndrome. Proc Natl Acad Sci USA 2000; 97: 2803–2808
   PubMed Web of Science ®Google Scholar
• Kanaji T, Russell S, Ware J. Amelioration of the macrothrombocytopenia associated with the murine Bernard-Soulier syndrome. Blood 2002; 100: 2102–2107
   PubMed Web of Science ®Google Scholar
• Denis C, Methia N, Frenettee PS, Rayburn H, Ullman-Cullere M, Hynes RO, Wagner DD. A mouse model of severe von Willebrand factor disease: Defects in haemostasis and thrombosis. Proc Natl Acad Sci USA 1998; 95: 9524–9529
   PubMed Web of Science ®Google Scholar
• Jirouskova M, Chereshnev I, Vaananen H, Degen JL, Coller BS. Antibody blockade or mutation of the fibrinogen gamma-chain C-terminus is more effective in inhibiting murine arterial thrombus formation than complete absence of fibrinogen. Blood 2004; 103: 1995–2002
   PubMed Web of Science ®Google Scholar
• Wang L, Miller C, Swarthout RF, Rao M, Mackman N, Taubman MB. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury. Blood 2009; 113: 705–713
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 2000; 96: 2520–2527
   PubMed Web of Science ®Google Scholar
• Wang X, Smith PL, Hsu MY, Gailani D, Schumacher WA, Ogletree ML, Sciffert DA. Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice. J Thromb Haemost 2006; 4: 1982–1988
   PubMed Web of Science ®Google Scholar
• Wang X, Smith PL, Hsu MY, Tamasi JA, Bird E, Schumacher WA. Deficiency in thrombin-activable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis. J Thromb Thrombolysis 2007; 23: 41–49
   PubMed Web of Science ®Google Scholar
• Wang X, Smith PL, Hsu MY, Ogletree ML, Schumacher WA. Murine model of ferric chloride-induced vena cava thrombosis: Evidence for effect of potato carboxypeptidase inhibitor. J Thromb Haemost 2006; 4: 403–410
   PubMed Web of Science ®Google Scholar
• Wadanoli M, Sako D, Shaw GD, Schaub RG, Wang Q, Tchernychev B, Xu J, Porter TJ, Huang Q. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time. Thromb Haemost 2007; 98: 397–405
   PubMed Web of Science ®Google Scholar
• Turitto VT, Baumgartner HR. Platelet-surface interactions. Hemostasis and thrombosis basic principles and clinical practice2nd, RW Colman, J Hirsh, VJ Marder, EW Saltzman. JP Lippincott Co., Philadelphia, PA 1987; 555–571
   Google Scholar
• Hanson SR, Sakariassen KS. Blood flow and antitrombotic drug effects. Am Heart J 1998; 135: s132–s145
   PubMed Web of Science ®Google Scholar
• Arya M, Anvari B, Romo GM, Cruz MA, Dong JF, McIntire LV, Moake JL, López JA. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: Studies using optical tweezers. Blood 2002; 99: 3971–3977
   PubMed Web of Science ®Google Scholar
• von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Köllnberger M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819–835, PMID: 22451716
   PubMed Web of Science ®Google Scholar
• Wang Y, Sakuma M, Chen Z, Ustinov V, Shi C, Croce K, Zago AC, Lopez J, Andre P, Plow E, et al. Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 2005; 112: 2993–3000, PMID: 16260637
   PubMed Web of Science ®Google Scholar